Buy HemoRel-A Dried Factor VIII Fraction IP

HemoRel-A Dried Factor VIII Fraction IP 500 IU vials support blood clotting for hemophilia A patients. Store between 2-8°C to maintain potency. Reliable clotting factor therapy from India for home or clinical use.

Strength

500 IU

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Reliance Life Sciences Pvt Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Dried Factor VIII Fraction IP is used to prevent or control bleeding episodes in patients with hemophilia A, a genetic disorder causing insufficient clotting factor VIII. It may also be used before surgery or dental procedures to reduce bleeding risk. This medication helps replace the missing clotting factor to support normal blood clotting processes.

Side Effects

After administration, Factor VIII works by binding to von Willebrand factor in the bloodstream to form a complex that participates in the clotting cascade. This helps stabilize blood clots and reduce prolonged bleeding. Patients may notice reduced bleeding frequency and improved wound healing following regular use.

Precautions & Warnings

Store vials refrigerated between 2–8°C and protect from light. Do not freeze. Use only if the solution is clear and free of particles. Discard any unused portion after reconstitution as directed. Keep out of reach of children and pets. Consult a healthcare provider before use if pregnant or breastfeeding.

Avoid Interactions

Factor VIII products may interact with other blood-related medications or therapies affecting coagulation. Avoid alcohol and herbal supplements that may affect bleeding risk. Inform your doctor about all prescription, over-the-counter, and alternative medicines. No known food interactions affect the efficacy of this product.

References

Frequently Asked Questions

HemoRel-A is used to treat and prevent bleeding in patients with hemophilia A by replacing missing clotting factor VIII.

Store HemoRel-A vials refrigerated between 2–8°C and protect from light. Do not freeze.

Consult a healthcare provider before using HemoRel-A if pregnant or breastfeeding to assess potential risks and benefits.

No, HemoRel-A requires a prescription as it is a clotting factor therapy used under medical supervision.

Do not use the vial if the solution appears cloudy or contains particles; discard it and use a new vial.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.